Analysis of Signal Transduction Machineries Involving Two Types of NELL Proteins in the Differentiation Process of Neural Crest-derived Cells
Analysis of Signal Transduction Machineries Involving Two Types of NELL Proteins in the Differentiation Process of Neural Crest-derived Cells
批准号:
15300126
负责人:
KURODA Shun'ichi
金额:
$10.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
NELL proteins (NELL1,NELL2), found in 1999 by us, possess a unique molecular organization. From N- to C-terminal, a signal peptide, thrombospondin 1-N terminal domain, EGF-like motifs, and vWF-derived motifs are found in both proteins. These Two 140-kDa proteins show about 55% similarity in the amino acid sequence level, are synthesized as a secreted protein, and form a about 400-kDa homotrimeric proteins. By our previous studies, since NELL1 mRNA was significantly expressed at the suture of craniocynostosis patients' skull, the NELL1 was finally demonstrated as a novel bone morphogenic protein(BMP). Unlike the conventional BMPs (e.x., BMP2,BMP4,BMP7), the NELL1 protein showed exclusively the induction of bone formation in osteoblast cells and not affected the determination of dorsal-ventral axes in the embryos.In this study, we established the continuous synthesis of NELL proteins using insect cell system (continuous, stable, and serum-free) and succeeded in the preparation of large amount of pure NELL proteins. These NELL proteins facilitated us to identify the novel molecules as candidates of NELL-specific receptors by using expression cloning techniques and analyze the 3D-structure by using an X-ray crystallographic technique. Furthermore, we succeeded in the establishing NELL1-overexpressing transgenic mice and NELL2-deflcieat mice for analyzing the physiological roles of NELL proteins.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yamada, T: "Nanoparticles for the Delivery of Genes and Drugs to Human Hepatocytes"Nature Biotechnology. 21. 885-890 (2003)
Yamada, T:“用于将基因和药物递送至人类肝细胞的纳米颗粒”《自然生物技术》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Spatial Learning of Mice Lacking a Neuron-Specific EGF Family Protein, NELL2.
缺乏神经元特异性 EGF 家族蛋白 NELL2 的小鼠的空间学习。
DOI:
--
发表时间:
2005
期刊:
J.Pharmacol.Sci. 98
影响因子:
--
作者:
[Matsuyama, S.]
通讯作者:
S.
Identification of a Tiss ue-non-specific Homologue of Axonal Fasciculation and Elongation Protein Zeta-1 (FEZ1).
轴突束收缩和伸长蛋白 Zeta-1 (FEZ1) 的组织非特异性同源物的鉴定。
DOI:
--
发表时间:
2004
期刊:
Biochem.Biophys.Res.Commun. 313
影响因子:
--
作者:
[Fujita, T.]
通讯作者:
T.
Zhang, X.: "Overexpression of Nell-1, a Craniosynostosis Associated Gene, Induces Apoptosis in Osteoblasts during Craniofacial Development"J.Bone Mineral Res.. 18. 2126-2134 (2003)
张,X.:“颅缝早闭相关基因 Nell-1 的过度表达,在颅面发育过程中诱导成骨细胞凋亡”J.Bone Mineral Res.. 18. 2126-2134 (2003)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
黒田俊一(分担執筆): "ナノバイオテクノロジーの最新技術"CMC出版. 23 (2003)
Shunichi Kuroda(撰稿人):“纳米生物技术的最新技术”CMC Publishing 23(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
仿生膜构建破骨细胞融合纳米诱饵用于骨质疏松治疗的研究
-
批准号:82372098
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:倪大龙
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
先天型成骨不全骨量失衡的病理机制及动物模型的研究
-
批准号:30973070
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:张浩
-
依托单位:
骨调素对山羊成骨细胞凋亡的调控机制
-
批准号:30571362
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2005
-
负责人:韩博
-
依托单位: